يعرض 1 - 10 نتائج من 208 نتيجة بحث عن '"F. Ciardiello"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials

    المؤلفون: G. Martini, D. Ciardiello, V. Famiglietti, D. Rossini, C. Antoniotti, T. Troiani, S. Napolitano, L. Esposito, T. P. Latiano, E. Maiello, M. Del Re, S. Lonardi, G. Aprile, D. Santini, G. Masi, A. Avallone, N. Normanno, F. Pietrantonio, C. Pinto, F. Ciardiello, C. Cremolini, E. Martinelli

    المصدر: Cancer Medicine, Vol 12, Iss 8, Pp 9392-9400 (2023)

    مصطلحات موضوعية: cetuximab, immunotherapy, metastatic colorectal cancer, rechallenge, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2045-7634Test

    الوصول الحر: https://doaj.org/article/873b18bc13684635ba23c522361014efTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression

    المؤلفون: S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello, T. Troiani

    المصدر: Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-18 (2019)

    مصطلحات موضوعية: Colorectal cancer, MEK inhibitor resistance, PD-L1 inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1756-9966Test

    الوصول الحر: https://doaj.org/article/34bdca4a0f844ee8a84e3ac3addc7986Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

    المؤلفون: J. Ventriglia, A. Petrillo, M. Huerta Alváro, M. M. Laterza, B. Savastano, V. Gambardella, G. Tirino, L. Pompella, A. Diana, F. Iovino, T. Troiani, E. Martinelli, F. Morgillo, M. Orditura, A. Cervantes, F. Ciardiello, F. De Vita

    المصدر: Gastroenterology Research and Practice, Vol 2018 (2018)

    مصطلحات موضوعية: Diseases of the digestive system. Gastroenterology, RC799-869

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1687-6121Test; https://doaj.org/toc/1687-630XTest

    الوصول الحر: https://doaj.org/article/fd62ed78bce447b9ab0bbccb5db83ef5Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Is there a role for adjuvant therapy in radiation-induced angiosarcoma of the breast? A case report and review of the literature

    المؤلفون: M. Caterino, M. De Felice, L. Poliero, G. Mazzarella, M. Pirozzi, S. Facchini, F. Ciardiello, M. Fasano

    المصدر: European Review for Medical and Pharmacological Sciences, Vol 27 (2023)

    مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950

    العلاقة: https://www.europeanreview.org/wp/wp-content/uploads/4169-4174.pdfTest; https://doaj.org/toc/1128-3602Test; https://doaj.org/article/06a5281fe193450fabd0eb7d9d1c7c20Test

    الإتاحة: https://doaj.org/article/06a5281fe193450fabd0eb7d9d1c7c20Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Securitization for common health

    المؤلفون: F. Ciardiello, E. Di Lorenzo, M. Menzietti, M. Sibillo

    المساهمون: Ciardiello, F., Di Lorenzo, E., Menzietti, M., Sibillo, M.

    مصطلحات موضوعية: Insurance risk, Financial engineering, Common health, PandemicSecuritized bond, COVID-19

    العلاقة: journal:SOCIO-ECONOMIC PLANNING SCIENCES; https://hdl.handle.net/11588/957389Test; https://doi.org/10.1016/j.seps.2024.101879Test

    الإتاحة: https://doi.org/10.1016/j.seps.2024.101879Test
    https://hdl.handle.net/11588/957389Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA : Individual patient data pooled analysis of CRICKET and CAVE trials

    المؤلفون: G. Martini, D. Ciardiello, V. Famiglietti, D. Rossini, C. Antoniotti, T. Troiani, S. Napolitano, L. Esposito, T. P. Latiano, E. Maiello, M. Del Re, S. Lonardi, G. Aprile, D. Santini, G. Masi, A. Avallone, N. Normanno, F. Pietrantonio, C. Pinto, F. Ciardiello, C. Cremolini, E. Martinelli

    المصدر: Cancer Medicine. 12:9392-9400

    مصطلحات موضوعية: Cancer Research, Oncology, Radiology, Nuclear Medicine and imaging

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3bece3d8b964d2a6bf52a9a99c5f78bfTest
    https://doi.org/10.1002/cam4.5699Test


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Central Nervous System as Possible Site of Relapse in ERBB2-PositiveMetastatic Colorectal Cancer:Long-term Results of TreatmentWith Trastuzumab and Lapatinib

    المؤلفون: A. Sartore Bianchi, S. Lonardi, M. Aglietta, C. Martino, F. Ciardiello, S. Marsoni, S. Siena

    المساهمون: A. Sartore Bianchi, S. Lonardi, M. Aglietta, C. Martino, F. Ciardiello, S. Marsoni, S. Siena

    مصطلحات موضوعية: Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32324210; info:eu-repo/semantics/altIdentifier/wos/WOS:000542037700021; journal:JAMA ONCOLOGY; http://hdl.handle.net/2434/720042Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084123738

    الإتاحة: https://doi.org/10.1001/jamaoncol.2020.0571Test
    http://hdl.handle.net/2434/720042Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial

    المؤلفون: A. Sartore-Bianchi, S. Lonardi, C. Martino, E. Fenocchio, F. Tosi, S. Ghezzi, F. Leone, F. Bergamo, V. Zagonel, F. Ciardiello, A. Ardizzoni, A. Amatu, K. Bencardino, E. Valtorta, E. Grassi, V. Torri, E. Bonoldi, A. Sapino, A. Vanzulli, D. Regge, G. Cappello, A. Bardelli, L. Trusolino, S. Marsoni, S. Siena

    المساهمون: A. Sartore-Bianchi, S. Lonardi, C. Martino, E. Fenocchio, F. Tosi, S. Ghezzi, F. Leone, F. Bergamo, V. Zagonel, F. Ciardiello, A. Ardizzoni, A. Amatu, K. Bencardino, E. Valtorta, E. Grassi, V. Torri, E. Bonoldi, A. Sapino, A. Vanzulli, D. Regge, G. Cappello, A. Bardelli, L. Trusolino, S. Marsoni, S. Siena

    مصطلحات موضوعية: Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000576969000001; volume:5; numberofpages:8; journal:ESMO OPEN; http://hdl.handle.net/2434/764890Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85092121940

    الإتاحة: https://doi.org/10.1136/esmoopen-2020-000911Test
    http://hdl.handle.net/2434/764890Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

    المؤلفون: E. Martinelli, T. Troiani, V. Sforza, G. Martini, C. Cardone, P. P. Vitiello, D. Ciardiello, A. M. Rachiglio, N. Normanno, A. Sartore-Bianchi, S. Marsoni, A. Bardelli, S. Siena, F. Ciardiello

    المساهمون: E. Martinelli, T. Troiani, V. Sforza, G. Martini, C. Cardone, P.P. Vitiello, D. Ciardiello, A.M. Rachiglio, N. Normanno, A. Sartore-Bianchi, S. Marsoni, A. Bardelli, S. Siena, F. Ciardiello

    مصطلحات موضوعية: colorectal cancer, her2 gene amplification, her2 inhibitor, next generation sequencing, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29387480; info:eu-repo/semantics/altIdentifier/wos/WOS:000428126600010; volume:3; issue:1; numberofpages:7; journal:ESMO OPEN; http://hdl.handle.net/2434/552356Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85047647967

    الإتاحة: https://doi.org/10.1136/esmoopen-2017-000299Test
    http://hdl.handle.net/2434/552356Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study

    المؤلفون: C. Cardone, A. De Stefano, G. Rosati, A. Cassata, L. Silvestro, M. Borrelli, E. Di Gennaro, C. Romano, A. Nappi, N. Zanaletti, F. Foschini, R. Casaretti, F. Tatangelo, S. Lastoria, M. Raddi, D. Bilancia, V. Granata, S. Setola, A. Petrillo, C. Vitagliano, P. Gargiulo, L. Arenare, A. Febbraro, E. Martinelli, F. Ciardiello, P. Delrio, A. Budillon, M.C. Piccirillo, A. Avallone

    المساهمون: Cardone, C, De Stefano, A, Rosati, G, Cassata, A, Silvestro, L, Borrelli, M, Di Gennaro, E, Romano, C, Nappi, A, Zanaletti, N, Foschini, F, Casaretti, R, Tatangelo, F, Lastoria, S, Raddi, M, Bilancia, D, Granata, V, Setola, S, Petrillo, A, Vitagliano, C, Gargiulo, P, Arenare, L, Febbraro, A, Martinelli, E, Ciardiello, F, Delrio, P, Budillon, A, Piccirillo, M C, Avallone, A

    مصطلحات موضوعية: second-line, Cancer Research, RAS mutant, Oncology, metastatic colorectal cancer, [(18)F]-FDG PET/CT, regorafenib

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4de1274e1101a4f09f6c89979c165bfTest
    https://hdl.handle.net/11591/486125Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث